San Diego, CA, United States of America

Konrad Feichtinger

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 6.1

ph-index = 10

Forward Citations = 207(Granted Patents)


Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Konrad Feichtinger: Innovator in Pharmaceutical Sciences

Introduction

Konrad Feichtinger, based in San Diego, California, is an inventive force in the realm of pharmaceutical sciences, holding an impressive portfolio of 20 patents. His contributions focus primarily on compounds that modulate serotonin receptors, reflecting his commitment to addressing various medical conditions.

Latest Patents

Among his latest innovations are two notable patents. The first is for 5-HT receptor agonists and compositions and methods of use. This invention includes compounds of Formula A that facilitate weight management, induce satiety, and decrease food intake. His work aims to provide treatments for a variety of conditions like obesity, type 2 diabetes, addiction disorders, and sleep disturbances.

The second patent involves 3-phenyl-pyrazole derivatives as modulators of the 5-HT serotonin receptor. This invention seeks to tackle disorders such as coronary artery disease, sleep disorders, and various psychiatric disorders, including schizophrenia and bipolar disorder. Feichtinger’s contributions are instrumental in developing therapies that address complex health issues.

Career Highlights

Feichtinger has had a fruitful career with experience in notable organizations such as Arena Pharmaceuticals and the University of California. His efforts in these institutions have solidified his reputation as a leader in the field of drug development and therapeutic innovations.

Collaborations

Throughout his career, Konrad Feichtinger has collaborated with prominent peers like Bradley Teegarden and Honnappa Jayakumar, enabling the acceleration of groundbreaking research and projects in pharmacology and therapeutics. These collaborations reflect a spirit of innovation and collective effort essential for advancing science.

Conclusion

Konrad Feichtinger exemplifies the essence of innovation within the pharmaceutical sector. With an extensive collection of patents and significant contributions to drug development, his work continues to impact the treatment of various medical conditions, paving the way for future advancements in health science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…